Antibe Therapeutics to Attend 2017 CPhI Worldwide Conference to Continue Partnering Discussions
(WorldNews Health)

TORONTO, CANADA - (October 20, 2017) - Antibe Therapeutics Inc. (`Antibe` or the `Company`) (TSXV: ATE, OTCQB: ATBPF) will be attending the 2017 CPhI Worldwide conference next week in Frankfurt, Germany. CPhI Worldwide is the world`s largest pharma trade show and considered the leading international pharmaceutical business and networking event. The event will be held on October 24th - 26th and will host over 42,000 pharma industry professionals from over 150 countries. Antibe will be meeting with several regional pharmaceutical companies to discuss potential out-licensing opportunities of ATB-346 in advance of clinical results from the on-going Phase 2b GI safety study - a data read-out...